title: Xigris is withdrawn from the market. A 10 year odyssey.
authors: P M
authors: PM
authors: Suter
mesh_terms: D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D057051:Product Recalls and Withdrawals; D011486:Protein C / Q000009:adverse effects* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D018570:Risk Assessment; D012772:Shock, Septic / Q000188:drug therapy
chemical_list: D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated